Birdwatch Note
2024-11-16 12:13:01 UTC - NOT_MISLEADING
Kennedy says he will stop drug development and redirect NIH to "study" chronic diseases. His words give no basis to assume drug development for chronic diseases would continue.
Written by 59D78E57BD54EBCA6F13FB54D1CE13EB54C904570B07128C57C5D371F1DAB670
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1857480985304277469
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1857758774007836812
- noteId - 1857758774007836812
- participantId -
- noteAuthorParticipantId - 59D78E57BD54EBCA6F13FB54D1CE13EB54C904570B07128C57C5D371F1DAB670 Participant Details
- createdAtMillis - 1731759181869
- tweetId - 1857480985304277469
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 0
- summary
- Kennedy says he will stop drug development and redirect NIH to "study" chronic diseases. His words give no basis to assume drug development for chronic diseases would continue.
Note Ratings
| rated at | rated by | |
| 2024-11-16 18:30:33 -0600 | Rating Details | |
| 2024-11-16 16:18:57 -0600 | Rating Details | |
| 2024-11-16 16:00:15 -0600 | Rating Details | |
| 2024-11-16 14:48:43 -0600 | Rating Details | |
| 2024-11-16 13:33:11 -0600 | Rating Details | |
| 2024-11-16 13:14:07 -0600 | Rating Details | |
| 2024-11-16 12:14:22 -0600 | Rating Details | |
| 2024-11-16 11:33:46 -0600 | Rating Details | |
| 2024-11-16 11:26:07 -0600 | Rating Details | |
| 2024-11-16 10:40:25 -0600 | Rating Details | |
| 2024-11-16 10:13:58 -0600 | Rating Details | |
| 2024-11-16 10:09:20 -0600 | Rating Details | |
| 2024-11-16 09:26:28 -0600 | Rating Details | |
| 2024-11-16 09:23:29 -0600 | Rating Details | |
| 2024-11-16 08:34:54 -0600 | Rating Details | |
| 2024-11-16 07:23:28 -0600 | Rating Details | |
| 2024-11-16 07:11:17 -0600 | Rating Details | |
| 2024-11-16 07:07:18 -0600 | Rating Details | |
| 2024-11-17 14:57:51 -0600 | Rating Details | |
| 2024-11-17 13:26:50 -0600 | Rating Details | |
| 2024-11-17 12:34:01 -0600 | Rating Details | |
| 2024-11-17 11:19:29 -0600 | Rating Details | |
| 2024-11-17 09:58:57 -0600 | Rating Details | |
| 2024-11-17 09:39:44 -0600 | Rating Details | |
| 2024-11-17 09:26:11 -0600 | Rating Details | |
| 2024-11-17 08:07:22 -0600 | Rating Details | |
| 2024-11-17 06:49:03 -0600 | Rating Details | |
| 2024-11-17 06:35:30 -0600 | Rating Details | |
| 2024-11-17 06:34:29 -0600 | Rating Details | |
| 2024-11-17 00:03:00 -0600 | Rating Details | |
| 2024-11-16 23:42:09 -0600 | Rating Details | |
| 2024-11-16 22:55:39 -0600 | Rating Details | |
| 2024-11-16 21:48:52 -0600 | Rating Details | |
| 2024-11-16 20:45:39 -0600 | Rating Details | |
| 2024-11-16 20:00:35 -0600 | Rating Details | |
| 2024-11-16 19:50:02 -0600 | Rating Details | |
| 2024-11-16 19:27:19 -0600 | Rating Details | |
| 2024-11-16 18:50:10 -0600 | Rating Details | |
| 2024-11-16 16:47:37 -0600 | Rating Details | |
| 2024-11-16 16:37:50 -0600 | Rating Details | |
| 2024-11-16 16:37:23 -0600 | Rating Details | |
| 2024-11-16 14:37:22 -0600 | Rating Details | |
| 2024-11-16 12:29:45 -0600 | Rating Details | |
| 2024-11-16 11:52:45 -0600 | Rating Details | |
| 2024-11-16 10:04:52 -0600 | Rating Details | |
| 2024-11-16 09:44:13 -0600 | Rating Details | |
| 2024-11-16 09:26:14 -0600 | Rating Details | |
| 2024-11-16 09:18:42 -0600 | Rating Details | |
| 2024-11-16 08:32:13 -0600 | Rating Details | |
| 2024-11-16 07:51:06 -0600 | Rating Details | |
| 2024-11-16 07:20:08 -0600 | Rating Details | |
| 2024-11-16 06:38:49 -0600 | Rating Details | |
| 2024-11-16 06:28:16 -0600 | Rating Details | |
| 2024-11-19 15:33:18 -0600 | Rating Details | |
| 2024-11-18 16:17:11 -0600 | Rating Details | |
| 2024-11-17 22:09:20 -0600 | Rating Details | |
| 2024-11-17 12:54:34 -0600 | Rating Details | |
| 2024-11-17 06:27:58 -0600 | Rating Details | |
| 2024-11-16 23:01:10 -0600 | Rating Details | |
| 2024-11-16 22:39:14 -0600 | Rating Details | |
| 2024-11-16 20:37:46 -0600 | Rating Details | |
| 2024-11-16 19:08:55 -0600 | Rating Details | |
| 2024-11-16 15:49:16 -0600 | Rating Details | |
| 2024-11-16 13:37:34 -0600 | Rating Details | |
| 2024-11-16 12:40:56 -0600 | Rating Details | |
| 2024-11-16 12:38:36 -0600 | Rating Details | |
| 2024-11-16 12:26:18 -0600 | Rating Details | |
| 2024-11-16 11:19:26 -0600 | Rating Details | |
| 2024-11-16 10:54:31 -0600 | Rating Details | |
| 2024-11-16 07:27:19 -0600 | Rating Details |